NFE2L2 and familial pancreatic carcinoma: Although NRF2 is known to promote tumor progression in pancreatic cancer (14, 15), it has also been implicated in tumor suppression in certain gastrointestinal malignancies, including chemically induced gastric (35) and colon (36) cancers.